Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3895 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

OccuLogix completes acquisition of Solx

Solx, a privately-held company developing new treatments for glaucoma, has developed its DeepLight system, which can be used to provide patients with multiple options for intraocular pressure reduction.

Sanofi Lovenox trial is postponed

The two generic drug manufacturers have been attempting to sell cheaper copies of Lovenox, a blood thinner, in the US. However, the patent does not expire until 2012.

Sanofi heart drug rejected by FDA

Multaq is an investigational therapeutic for atrial flutters or fibrillations, a condition that affects approximately $2 million Americans. The application was made last year and Euroepan regulators are